Introduction Osteoporosis is a major public health concern, particularly among postmenopausal women. Characterized by low bone mineral density (BMD) and compromised bone microarchitecture, osteoporosis significantly increases the risk of fractures, leading to morbidity and reduced quality of life. While antiresorptive therapies like bisphosphonates